KIP — Kolinpharma SpA Income Statement
0.000.00%
Last trade - 00:00
HealthcareBalancedMicro Cap
- €15.98m
- €15.21m
- €14.06m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.17 | 8.92 | 8.2 | 11.2 | 14.1 |
Cost of Revenue | |||||
Gross Profit | 2.87 | 4.5 | 4.56 | 6.61 | 7.93 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.62 | 8.05 | 7.21 | 10 | 13.2 |
Operating Profit | 0.549 | 0.866 | 0.993 | 1.15 | 0.83 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.462 | 0.795 | 0.886 | 0.918 | 0.595 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.275 | 0.591 | 0.642 | 0.637 | 0.342 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.275 | 0.591 | 0.642 | 0.637 | 0.342 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.275 | 0.591 | 0.642 | 0.637 | 0.342 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.168 | 0.431 | 0.392 | 0.408 | 0.262 |
Dividends per Share |